How have CGON shares performed in 2024?

CG Oncology's stock was trading at $37.17 at the beginning of 2024. Since then, CGON stock has increased by 11.8% and is now trading at $41.57. View the best growth stocks for 2024 here .

When did CG Oncology IPO?

(CGON) raised $380 million in an initial public offering on Thursday, January 25th 2024. The company issued 20,000,000 shares at $19.00 per share.

When does CG Oncology's quiet period expire?

CG Oncology's quiet period expires on Tuesday, March 5th. CG Oncology had issued 20,000,000 shares in its IPO on January 25th. The total size of the offering was $380,000,000 based on an initial share price of $19.00. During CG Oncology's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of CG Oncology?

Shares of CGON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CGON

CG Oncology (CGON) Stock Price, News & Analysis

$41.57

+2.55 (+6.54%)

(As of 02/9/2024 08:56 PM ET)

Compare

Today's Range: $38.68
▼
$43.76
50-Day Range: N/A
52-Week Range: $28.55
▼
$44.91

Volume: 575,600 shs
Average Volume: 950,018 shs
Market Capitalization: $2.64 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Insider Trades SEC Filings Social Media

Get CG Oncology alerts:

About CG Oncology Stock (NASDAQ:CGON)

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

CGON Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CGON Stock News Headlines

February 9, 2024 | morningstar.com

CG Oncology Inc CGON

February 9, 2024 | finance.yahoo.com

CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

February 12, 2024 | Edge On The Street (Ad)

An Unusual Way to Invest in Gold

Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.

February 3, 2024 | americanbankingnews.com

Insider Buying: CG Oncology, Inc. Common stock (NASDAQ:CGON) CFO Acquires 2,000 Shares of Stock

February 3, 2024 | americanbankingnews.com

CG Oncology, Inc. Common stock (NASDAQ:CGON) Insider Buys $24,985.00 in Stock

February 3, 2024 | americanbankingnews.com

CG Oncology, Inc. Common stock (NASDAQ:CGON) Director Acquires $4,999,983.00 in Stock

February 2, 2024 | americanbankingnews.com

Decheng Capital Global Life Sc Acquires 400,000 Shares of CG Oncology, Inc. Common stock (NASDAQ:CGON) Stock

See More Headlines

Receive CGON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 2/11/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:CGON
Previous Symbol: NASDAQ:CGON
CUSIP: N/A
CIK: 1991792
Web: cgoncology.com
Phone: 949-419-6203
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 63,480,000
Free Float: N/A
Market Cap: $2.64 billion
Optionable: N/A
Beta: N/A

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

CGON Stock Analysis - Frequently Asked Questions

How have CGON shares performed in 2024?: CG Oncology's stock was trading at $37.17 at the beginning of 2024. Since then, CGON stock has increased by 11.8% and is now trading at $41.57.
View the best growth stocks for 2024 here.
When did CG Oncology IPO?: (CGON) raised $380 million in an initial public offering on Thursday, January 25th 2024. The company issued 20,000,000 shares at $19.00 per share.
When does CG Oncology's quiet period expire?: CG Oncology's quiet period expires on Tuesday, March 5th. CG Oncology had issued 20,000,000 shares in its IPO on January 25th. The total size of the offering was $380,000,000 based on an initial share price of $19.00. During CG Oncology's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
How do I buy shares of CG Oncology?: Shares of CGON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CGON) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CG Oncology (CGON) Stock Price, News & Analysis

About CG Oncology Stock (NASDAQ:CGON)

CGON Stock Price History

CGON Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

Insiders

CGON Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info